A Phase I trial of talazoparib in patients with advanced hematologic malignancies
{{output}}
Aim: The objective of this study was to establish the maximum tolerated dose (MTD), safety, pharmacokinetics, and anti-leukemic activity of talazoparib. Patients ... ...